FDA
approval
· 2022-10-25
FDA Approved: TECVAYLI — Original Application (Janssen Biotech, Inc.)
Summary
FDA approved TECVAYLI (teclistamab-cqyv) from Janssen Biotech, Inc. as an original application for the treatment of multiple myeloma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TECVAYLI (TECLISTAMAB-CQYV)